Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3333-3337

  Hussain, S Perwez ^a   Amstad, Paul ^a,b   Raja, Kamran ^a   Ambs, Stefan ^a,c   Nagashima, Makoto ^a   Bennett, William P ^a,d   Shields, Peter G ^a   Ham, Amy Joan ^a,e   Swenberg, James A ^a,e   Marrogi, Aizen J ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Intergen Discovery Products   (United States)

^c Aventis Biopharmaceuticals   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENETIC DAMAGE; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ADULT; CODON; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; DINUCLEOSIDE PHOSPHATES; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTESTINAL MUCOSA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POINT MUTATION; REFERENCE VALUES;

EID: 0346606862     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Lennard-Jones, J. E., Morson, B. C., Ritchie, J. K., Shove, D. C., and Williams, C. B. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology, 73: 1280-1289, 1977.
2. Lashner, B. A., Silverstein, M. D., and Hanauer, S. B. Hazard rates for dysplasia and cancer in ulcerative colitis: results from a surveillance program. Dig. Dis. Sci., 34: 1536-1541, 1989.
3. Fearon, E. R. Molecular genetic studies of the adenoma-carcinoma sequence. Adv. Intern. Med., 39: 123-147, 1994.
4. Riddell, R. H., Goldman, H., Ransohoff, D. F., Appelman, H. D., Fenoglio, C. M., Haggitt, R. C., Ahren, C., Correa, P., Hamilton, S. R., and Morson, B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol., 14: 931-968, 1983.
5. Rabinovitch, P. S., Dziadon, S., Brentnall, T. A., Emond, M. J., Crispin, D. A., Haggitt, R. C., and Bronner, M. P. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res., 59: 5148-5153, 1999.
6. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
7. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525-532, 1988.
8. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
9. Aust, D. E., Willenbucher, R. F., Terdiman, J. P., Ferrell, L. D., Chang, C. G., Moore, D. H., Molinaro-Clark, A., Baretton, G. B., Loehrs, U., and Waldman, F. M. Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. Hum Pathol., 31: 109-114, 2000.
10. Burmer, G. C., Levine, D. S., Kulander, B. G., Haggitt, R. C., Rubin, C. E., and Rabinovitch, P. S. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology, 99: 416-420, 1990.
11. Tarmin, L., Yin, J., Harpaz, N., Kozam, M., Noordzij, J., Antonio, L. B., Jiang, H. Y., Chan, O., Cymes, K., and Meltzer, S. J. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res., 55: 2035-2038, 1995.
12. Kern, S. E., Redston, M., Seymour, A. B., Caldas, C., Powell, S. M., Kornacki, S., and Kinzler, K. W. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology, 107: 420-428, 1994.
13. Redston, M. S., Papadopoulos, N., Caldas, C., Kinzler, K. W., and Kern, S. E. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology, 108: 383-392, 1995.
14. Baker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S., Willson, J. K., Hamilton, S., and Vogelstein, B. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res., 50: 7717-7722, 1990.
15. Yin, J., Harpaz, N., Tong, Y., Huang, Y., Laurin, J., Greenwald, B. D., Hontanosas, M., Newkirk, C., and Meltzer, S. J. p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology, 104: 1633-1639, 1993.
16. Holzmann, K., Klump, B., Borchard, F., Hsieh, C. J., Kuhn, A., Gaco, V., Gregor, M., and Porschen, R. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int. J. Cancer, 76: 1-6, 1998.
17. Lashner, B. A., Shapiro, B. D., Husain, A., and Goldblum, J. R. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am. J. Gastroenterol., 94: 456-462, 1999.
18. Lang, S. M., Stratakis, D. F., Heinzlmann, M., Heldwein, W., Wiebecke, B., and Loeschke, K. Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki-ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonie lavage fluid. Gut, 44: 822-825, 1999.
19. Kinzler, K. W., and Vogelstein, B. Landscaping the cancer terrain. Science (Washington DC), 280: 1036-1037, 1998.
20. Nathan, C., and Xie, Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell, 78: 915-918, 1994.
21. Tamir, S., and Tannenbaum, S. R. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta, 1288: F31-F36, 1996.
22. Ambs, S., Hussain, S. P., and Harris, C. C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11: 443-448, 1997.
23. Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Harrington, A. M., Shields, P. G., Felley-Bosco, E., Hussain, S. P., and Harris, C. C. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst., 91: 86-88, 1999.
24. Ambs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., and Harris, C. C. p53 and vascular endothelial growth factor regulate tumour growth of NOS2-expressing human carcinoma cells. Nat. Med., 4: 1371-1376, 1998.
25. Singer, I. I., Kawka, D. W., Scott, S., Weidner, J. R., Mumford, R. A., Riehl, T. E., and Stenson, W. F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology, 111: 871-885, 1996.
26. Maeda, H., and Akaike, T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry, 63: 854-865, 1998.
27. Ambs, S., Hussain, S. P., Marrogi, A. J., and Harris, C. C. Cancer-prone oxyradical overload disease. IARC Sci. Publ., 150: 295-302, 1999.
28. Wink, D. A., Vodovotz, Y., Laval, J., Laval, F., Dewhirst, M. W., and Mitchell, J. B. The multi faceted roles of nitric oxide in cancer. Carcinogenesis (Lond.), 19: 711-721, 1998.
29. Anreder, M. B., Freeman, S. M., Merogi, A., Halabi, S., and Marrogi, A. J. p53, c-erbB2, and PCNA status in benign, proliferative and malignant ovarian surface epithelial neoplasms: a study of 75 cases. Arch. Pathol. Lab. Med., 123: 310-316, 1999.
30. Aguilar, F., Hussain, S. P., and Cerutti, P. Aflatoxin B1 induces the transversion of G→T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci USA, 90: 8586-8590, 1993.
31. Hussain, S. P., Aguilar, F., Amstad, P., and Cerutti, P. Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene. Oncogene, 9: 2277-2281, 1994.
32. Ambs, S., Merriam, W. G., Bennett, W. P., Felley-Bosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58: 334-341, 1998.
33. Kolios, G., Rooney, N., Murphy, C. T., Robertson, D. A., and Westwick, J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut, 43: 56-63, 1998.
34. Gal, A., and Wogan, G. N. Mutagenesis associated with nitric oxide production in transgenic SJL mice. Proc. Natl. Acad. Sci USA, 93: 15102-15107, 1996.
35. Juedes, M. J., and Wogan, G. N. Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res., 349: 51-61, 1996.
36. Christen, S., Hagen, T. M., Shigenaga, M. K., and Ames, B. N. Chronic inflammation, mutation, and cancer. In: J. Parsonnet and S. Hornig (eds.), Microbes and Malignancy: Infection as a Cause of Cancer, pp. 35-88. New York: Oxford University Press, 1999.
37. Harris, C. C. Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol. Biomark. Prev., 3: 1-2, 1994.
38. Beasley, R. P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer (Phila.), 61: 1942-1956, 1988.
39. Bansal, P., and Sonnenberg, A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology, 109: 247-251, 1995.
40. Rosin, M. P., Anwar, W. A., and Ward, A. J. Inflammation, chromosomal instability, and cancer: the schislosomiasis model. Cancer Res., 54: 1929s-1933s, 1994.
41. Asaka, M., Takeda, H., Sugiyama, T., and Kato, M. What role does Helicobacter pylori play in gastric cancer? Gastroenterology, 113: S56-S60, 1997.
42. Poulsen, H. E., Prieme, H., and Loft, S. Role of oxidative DNA damage in cancer initiation and promotion. Eur. J. Cancer Prev., 7: 9-16, 1998.
43. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
44. Hussain, S. P., and Harris, C. C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res., 58: 4023-4037, 1998.
45. deRojas-Walker, T., Tamir, S., Ji, H., Wishnok, J. S., and Tannenbaum, S. R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem. Res. Toxicol., 8: 473-477, 1995.
46. Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., and Tannenbaum, S. R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci USA, 89: 3030-3034, 1992.
47. Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., and Keefer, L. K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Washington DC), 254: 1001-1003, 1991.
48. Beckman, J. S., Chen, J., Ischiropoulos, H., and Crow, J. P. Oxidative chemistry of peroxynitrite. Methods Enzymol., 233: 229-240, 1994.
49. Yermilov, V., Rubio, J., Becchi, M., Friesen, M. D., Pignatelli, B., and Ohshima, H. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis (Lond.), 16: 2045-2050, 1995.
50. Burney, S., Niles, J. C., Dedon, P. C., and Tannenbaum, S. R. DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite. Chem. Res. Toxicol., 12: 513-520, 1999.
51. Miles, A. M., Bohle, D. S., Glassbrenner, P. A., Hansert, B., Wink, D. A., and Grisham, M. B. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem., 271: 40-47, 1996.
52. Wink, D. A., and Mitchell, J. B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radical Biol. Med., 25: 434-456, 1998.
53. Duthie, G. G. Lipid peroxidation. Eur. J. Clin. Nutr., 47: 759-764, 1993.
54. Chung, F. L., Chen, H. J., and Nath, R. G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis (Lond.), 17: 2105-2111, 1996.
55. Nair, J., Barbin, A., Velic, I., and Bartsch, H. Etheno DNA-base adducts from endogenous reactive species. Mutat. Res., 424: 59-69, 1999.